A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

The 85th American Diabetes Association Scientific Sessions have shown the depth of China’s play for the GLP-1 market, with ...

With semaglutide and tirzepatide dosed once weekly, their estimated average yearly costs in the U.S. are $14,080 and $8,126, respectively. What's more, obesity alone as an indication bars coverage ...

Study comparing bariatric surgery to GLP-1 medications shows 24% total weight loss from surgery versus 4.7% from injectables, with many patients quitting GLP-1 treatment within a year.

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

Researchers found after bariatric procedures, patients lost an average of 58 pounds after two years, compared to 12 pounds ...

But up to 70% of people taking a GLP-1 drug stop treatment within one year, Brown noted. Early discontinuation is a “big part” of why the medications are less effective in the real world ...